logo
logo
logo
logo
  • News
  • Approach
  • ESG
  • Portfolio
  • Team
  • Tech Investments
  • Contact

4SC's Resminostat shows survival benefit

5. October 2016
|In Portfolio News
|By eazee-designstudio

4SC’s Resminostat shows survival benefit

5. October 2016
|In Portfolio News
|By eazee-designstudio

Subgroup analysis suggests survival benefit in patients with advanced liver cancer treated with resminostat

  • Prev
  • Next

© 2022 Wellington Partners. All rights reserved  |  Imprint  |  Privacy Policy | SFDR Disclosures | PRIIPS

Privacy Preference Center

Privacy Preferences